Never miss an update from Gilead Sciences. Did you know that during reporting season, the announcements from NASDAQ:GILD often move the market?
|52w High/Low:||$60.89 - 85.97|
|Volume/Average:||11M - 19.1M|
Listed in 1992Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need... More
Investors seem to think so based on new data for Gilead Sciences' potential COVID-19 treatment.Better Buy: Bristol Myers Squibb vs. Gilead Sciences
Which of these household names is the better buy?Biotech Stocks: Buy This, Not That
Here's how one biotech company can make investors rich, and why another should be avoided.Better Coronavirus Stock: Gilead Sciences or Novavax?
Between a big biotech with the leading COVID-19 therapy and a small biotech with a promising COVID-19 vaccine candidate, which stock wins?Why Carnival, Royal Caribbean, and Norwegian Cruise Line Stocks Rose Today
Cruise ship investors cheered hopeful coronavirus news.Vir Biotechnology Is Bucking The Biotech COVID-19 Trends, And Stands To Win
The company is an aggressive newcomer to the infectious-disease market and its COVID-19 programs are very promising.Here's Why Arcus Biosciences Stock Gained as Much as 15.9% Today
The development-stage biopharma is bouncing back from a recent stock dip.Don't Waste Your Money on Penny Stocks; These 3 Are Better Buys
Unlike most penny stocks, these three companies are leaders in their respective industries and could provide market-beating returns for a while.